Lithium

inositol polyphosphate-1-phosphatase ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33172890 A structural basis for lithium and substrate binding of an inositide phosphatase. 2021 Jan-Jun 3
2 31875781 Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and Dependence. 2019 1
3 26267417 Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes. 2015 Oct 4
4 19442155 Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). 2009 4
5 17570738 The pharmacogenetics of lithium response depends upon clinical co-morbidity. 2007 2
6 15471909 Molecular effects of lithium. 2004 Oct 1
7 11909602 Pharmacogenetics in affective disorders. 2002 Mar 8 1
8 11966408 Lithium long-term treatment in mood disorders: clinical and genetic predictors. 2002 Jan 1
9 11343583 Prediction of lithium response by 31P-MRS in bipolar disorder. 2000 Mar 1
10 10347153 A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3'-phosphoadenosine 5'-phosphate phosphatase and inositol-polyphosphate 1-phosphatase. 1999 Jun 4 1
11 10780272 Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1). 1999 Aug 8
12 9682271 The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. 1998 Jun 3
13 8390685 Cloning, heterologous expression, and chromosomal localization of human inositol polyphosphate 1-phosphatase. 1993 Jun 15 1